Sign In
Buy ABBV
$224.93
+7.86 (+3.62%)
At Close: Jun 04, 2026
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
06:45am, Thursday, 16'th Oct 2025
The idea of steady money flowing in, year after year, should appeal to nearly everyone. This isn't an unrealistic dream; investing in stocks that pay reliable dividends can make it a reality.
AbbVie (ABBV) Stock Falls Amid Market Uptick: What Investors Need to Know
06:46pm, Wednesday, 15'th Oct 2025
The latest trading day saw AbbVie (ABBV) settling at $226.22, representing a -1.27% change from its previous close.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to addres
Can Rinvoq and Skyrizi Sales Drive Another Strong Quarter for AbbVie?
12:11pm, Tuesday, 14'th Oct 2025
ABBV leans on booming Skyrizi and Rinvoq-driven sales to sustain growth and counter Humira's decline as Q3 results approach.
Final Trades: Abbvie, Amazon, Datadog and Sixth Street Specialty Lending
01:28pm, Monday, 13'th Oct 2025
The Investment Committee give you their top stocks to watch for the second half.
- Updated indication allows the use of RINVOQ® (upadacitinib) prior to the use of tumor necrosis factor (TNF) blocking agents in patients for whom use of these treatments is clinically ina
2 Dividend Stocks to Double Up on Right Now
09:53am, Monday, 13'th Oct 2025
Dividend stocks never go out of style, but they might be even more worthy of consideration right now because some evidence suggests that troubles lie ahead. The government shutdown and remaining uncer
AbbVie to Present New Data at ESMO 2025 Reinforcing Leadership in Advancing Targeted Therapies for Solid Tumors
07:15am, Monday, 13'th Oct 2025
New data from telisotuzumab adizutecan (Temab-A) and ABBV-706 across pancreatic, colorectal, and solid tumors, highlight progress in AbbVie's growing ADC portfolio designed to target difficult-to-tre
Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?
10:01am, Friday, 10'th Oct 2025
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Carolina Wealth Trims It's AbbVie Stake to Nearly Nothing
11:19am, Thursday, 09'th Oct 2025
Carolina Wealth Advisors, LLC disclosed in an Oct. 7, 2025, U.S. Securities and Exchange Commission filing that it sold 38,267 AbbVie shares for the quarter ended Sept. 30, 2025, an estimated $7.79 mi
AbbVie vs. Eli Lilly: Which Large Drugmaker Has the Edge in 2025?
11:16am, Thursday, 09'th Oct 2025
Lilly's explosive GLP-1 growth and AbbVie's post-Humira rebound set up a fierce 2025 showdown between two pharma powerhouses.
SkinMedica® Debuts Reimagined Packaging and Unveils New HA5® Hydra Collagen Water Burst Moisturizer
08:00am, Thursday, 09'th Oct 2025
By the makers of BOTOX® Cosmetic (onabotulinumtoxinA), SkinMedica®'s new packaging features a refreshed logo, modernized look, and luxe copper color palette. The brand's new HA5® moisturizer is des
Why AbbVie and Johnson & Johnson Could Outperform Pfizer
07:17am, Wednesday, 08'th Oct 2025
Pfizer Inc. NYSE: PFE made a strong move higher after it became the first drug manufacturer to sign on as part of the TrumpRx platform. PFE stock is up nearly 14% since its closing price of around $23
Why AbbVie Stock Soared in September
03:41am, Wednesday, 08'th Oct 2025
Any pharmaceutical company as large and sprawling as AbbVie (ABBV 1.41%) never stops being busy, from pushing investigational drugs along the development pipeline to shipping blockbuster medications t
3 Dividend Stocks to Double Up On Right Now
04:44am, Tuesday, 07'th Oct 2025
If x is good, isn't 2x even better? Usually. Granted, there can be too much of a good thing.
